Related Experiment Video
Updated: Apr 28, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon, interleukin-2, and other cytokines.
Elizabeth I Buchbinder1, David F McDermott1
1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.
This review covers cytokine therapy for melanoma, focusing on interferon-alfa and interleukin-2. It also discusses clinical strategies for patient selection, toxicity reduction, and combination treatments for better outcomes.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Cytokines are crucial signaling molecules mediating immune responses.
- Melanoma treatment has evolved with immunotherapeutic approaches.
- Cytokine therapy offers a way to modulate the immune system against cancer.
Purpose of the Study:
- To review the use of cytokine therapy in melanoma.
- To highlight the roles of interferon-alfa and interleukin-2.
- To discuss clinical considerations for optimizing cytokine therapy.
Main Methods:
- Literature review of cytokine therapy applications in melanoma.
- Focus on clinical studies involving interferon-alfa and interleukin-2.
- Analysis of patient selection criteria and toxicity management.
Main Results:
- Interferon-alfa and interleukin-2 are key cytokines used in melanoma treatment.
- Effective patient selection is vital for successful outcomes.
- Strategies exist to mitigate treatment-related toxicities.
- Combination regimens may enhance therapeutic efficacy.
Conclusions:
- Cytokine therapy, particularly with interferon-alfa and interleukin-2, remains relevant in melanoma management.
- Careful patient selection and toxicity management are essential.
- Further research into combination strategies can improve melanoma treatment protocols.
More Related Videos
10:10Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The JAK-STAT Signaling Pathway
Tumor Immunotherapy